{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-012533","form_type":"8-K/A","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.781055+00:00","generated_at":"2026-05-18T09:31:48.862564+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Medicus Pharma signs share exchange agreement to acquire Antev Limited","bullets":["Agreement to acquire all Antev Shares; Antev becomes wholly-owned subsidiary of Medicus.","Consideration includes Purchaser Shares (Consideration Shares) and Contingent Consideration tied to milestones.","Antev's lead candidate Teverelix (for acute urinary retention) referenced in forward-looking statements.","Closing expected 3 Business Days after conditions satisfied; drag-along provisions apply for all shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-012533","json":"https://secwatch.observer/filing/0001062993-25-012533.json","markdown":"https://secwatch.observer/filing/0001062993-25-012533.md","text":"https://secwatch.observer/filing/0001062993-25-012533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325012533/0001062993-25-012533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325012533/form8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:31:48.862564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}